Skip to content

Nefopam vs ketorolac combined in oxycodone patient-controlled analgesia after gynecologic surgery

Nefopam vs ketorolac combined in oxycodone patient-controlled analgesia after gynecologic surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001236
Enrollment
120
Registered
2014-09-24
Start date
2014-07-04
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 120 patients admitted for elective gynecologic surgery, who are ASA (American Society of Anesthesiologist) physical status classification class I or II and aged 18 to 65 years old, will be included.

Exclusion criteria

Exclusion criteria: Patients, who do not qualify for or do not prefer treatment of opioids or NSAIDs, or who have psychological disorder, chronic pain disorder or preoperative administration of drugs including opioids, antidepressants, gabapentin, pregabalin, and carbamazepine, will be excluded. Patients, who cannot use numerical rating scale (NRS), who have increased intracranial pressure, renal failure, hepatic failure, or in pregnancy, will be excluded.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS)

Secondary

MeasureTime frame
accumulated PCA dose;Visual analogue scale (VAS) ;headache, shivering, nausea/vomiting, pruritus;satisfaction

Countries

Korea, Republic of

Contacts

Public ContactJae young Kwon

Pusan National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026